BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11348470)

  • 1. Retinoic acid upregulates the plasminogen activator system in human epidermal keratinocytes.
    Braungart E; Magdolen V; Degitz K
    J Invest Dermatol; 2001 May; 116(5):778-84. PubMed ID: 11348470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of urokinase A chain with the receptor of human keratinocytes stimulates release of urokinase-like plasminogen activator.
    Fibbi G; Magnelli L; Pucci M; Del Rosso M
    Exp Cell Res; 1990 Mar; 187(1):33-8. PubMed ID: 2153567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high-affinity receptor for urokinase plasminogen activator on human keratinocytes: characterization and potential modulation during migration.
    McNeill H; Jensen PJ
    Cell Regul; 1990 Oct; 1(11):843-52. PubMed ID: 1965151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression and localization of urokinase-type plasminogen activator and its type 1 inhibitor are regulated by retinoic acid and fibroblast growth factor in human teratocarcinoma cells.
    Tienari J; Alanko T; Lehtonen E; Saksela O
    Cell Regul; 1991 Apr; 2(4):285-97. PubMed ID: 1905574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced production of plasminogen activator activity in human and murine keratinocytes by transforming growth factor-beta 1.
    Keski-Oja J; Koli K
    J Invest Dermatol; 1992 Aug; 99(2):193-200. PubMed ID: 1629632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of specific membrane receptors in urokinase-dependent migration of human keratinocytes.
    Del Rosso M; Fibbi G; Dini G; Grappone C; Pucci M; Caldini R; Magnelli L; Fimiani M; Lotti T; Panconesi E
    J Invest Dermatol; 1990 Mar; 94(3):310-6. PubMed ID: 2155272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas.
    Pyke C; Kristensen P; Ralfkiaer E; Grøndahl-Hansen J; Eriksen J; Blasi F; Danø K
    Am J Pathol; 1991 May; 138(5):1059-67. PubMed ID: 1850957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of retinoic acid on plasminogen activators in murine epidermal cell culture.
    Brown JM; Cohen RL; Chambers DA
    Ann N Y Acad Sci; 1992 Dec; 667():50-1. PubMed ID: 1309071
    [No Abstract]   [Full Text] [Related]  

  • 9. Keratinocyte urokinase-type plasminogen activator is secreted as a single chain precursor.
    Hashimoto K; Prystowsky JH; Baird J; Lazarus GS; Jensen PJ
    J Invest Dermatol; 1988 Jun; 90(6):823-8. PubMed ID: 2967334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis.
    Baird J; Lazarus GS; Belin D; Vassalli JD; Busso N; Gubler P; Jensen PJ
    J Invest Dermatol; 1990 Nov; 95(5):548-52. PubMed ID: 2121833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of auranofin and retinoic acid on plasminogen activator activity of peritoneal macrophages and Lewis lung carcinoma cells.
    Lison D; Knoops B; Collette C; Lauwerys R
    Biochem Pharmacol; 1989 Jul; 38(13):2107-12. PubMed ID: 2500127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta modulates plasminogen activator activity and plasminogen activator inhibitor type-1 expression in human keratinocytes in vitro.
    Wikner NE; Elder JT; Persichitte KA; Mink P; Clark RA
    J Invest Dermatol; 1990 Nov; 95(5):607-13. PubMed ID: 2230225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors.
    Blasi F; Vassalli JD; Danø K
    J Cell Biol; 1987 Apr; 104(4):801-4. PubMed ID: 3031083
    [No Abstract]   [Full Text] [Related]  

  • 14. Modulation of urokinase-type plasminogen activator messenger RNA levels in human synovial fibroblasts by interleukin-1, retinoic acid, and a glucocorticoid.
    Vitti G; Hamilton JA
    Arthritis Rheum; 1988 Aug; 31(8):1046-51. PubMed ID: 3136776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts.
    Hamilton JA; Piccoli DS; Leizer T; Butler DM; Croatto M; Royston AK
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7180-4. PubMed ID: 1908092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of plasminogen activator on epidermal cell migration].
    Nakajima S; Morioka S
    Nihon Hifuka Gakkai Zasshi; 1990 Oct; 100(11):1199-201. PubMed ID: 2148779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester.
    Rørth P; Nerlov C; Blasi F; Johnsen M
    Nucleic Acids Res; 1990 Sep; 18(17):5009-17. PubMed ID: 2119494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptic urokinase binding sites on human foreskin fibroblasts.
    Bajpai A; Baker JB
    Biochem Biophys Res Commun; 1985 Dec; 133(2):475-82. PubMed ID: 3002345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The growth factor module of urokinase is the binding sequence for its receptor.
    Appella E; Blasi F
    Ann N Y Acad Sci; 1987; 511():192-5. PubMed ID: 2830824
    [No Abstract]   [Full Text] [Related]  

  • 20. All-trans retinoic acid stimulates growth of adult human keratinocytes cultured in growth factor-deficient medium, inhibits production of thrombospondin and fibronectin, and reduces adhesion.
    Varani J; Nickoloff BJ; Dixit VM; Mitra RS; Voorhees JJ
    J Invest Dermatol; 1989 Oct; 93(4):449-54. PubMed ID: 2476509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.